English | 繁體

Search in the results

UM

Browse/Search Results:  1-4 of 4 Help

Selected(0)Clear Items/Page:    Sort:
Long-Term Clinical and Economic Effects of Switching to Once-Weekly Semaglutide from Other GLP-1 RAs Among Patients with Type 2 Diabetes in China: A Modeling Projection Study Journal article
Hu, Ying, Chen, Xianwen, Zou, Huimin, Zhang, Hao, Ni, Qi, Li, Yijun, Ung, Carolina Oi Lam, Hu, Hao, Mu, Yiming. Long-Term Clinical and Economic Effects of Switching to Once-Weekly Semaglutide from Other GLP-1 RAs Among Patients with Type 2 Diabetes in China: A Modeling Projection Study[J]. Advances in Therapy, 2024.
Authors:  Hu, Ying;  Chen, Xianwen;  Zou, Huimin;  Zhang, Hao;  Ni, Qi; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.4/4.0 | Submit date：2024/12/26
China  Modeling  Semaglutide  Type 2 Diabetes Mellitus  
Novel clinical biomarkers in blood and pleural effusion for diagnosing patients with tuberculosis distinguishing from malignant tumor Journal article
Wang Jian, Feng ZheXiang, Ren Tao, Meng WeiYu, Khan Imran, Fan XingXing, Pan HuDan, Liu Liang, Tang YiJun, Yao XiaoJun, Li RunZe, Wang MeiFang, Leung Elaine Lai Han. Novel clinical biomarkers in blood and pleural effusion for diagnosing patients with tuberculosis distinguishing from malignant tumor[J]. MEDICINE, 2022, 101(41), E31027.
Authors:  Wang Jian;  Feng ZheXiang;  Ren Tao;  Meng WeiYu;  Khan Imran; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:1.3/1.6 | Submit date：2022/11/07
Biomarker  Cancerous  Diagnosis  Pleural Effusion  Tuberculous  
An AR-ERG transcriptional signature defined by longrange chromatin interactomes in prostate cancer cells Journal article
Zhang,Zhizhuo, Chng,Kern Rei, Lingadahalli,Shreyas, Chen,Zikai, Liu,Mei Hui, Do,Huy Hoang, Cai,Shaojiang, Rinaldi,Nicola, Poh,Huay Mei, Li,Guoliang, Sung,Ying Ying, Heng,Charlie L., Core,Leighton J., Tan,Si Kee, Ruan,Xiaoan, Lis,John T., Kellis,Manolis, Ruan,Yijun, Sung,Wing Kin, Cheung,Edwin. An AR-ERG transcriptional signature defined by longrange chromatin interactomes in prostate cancer cells[J]. Genome Research, 2019, 29(2), 223-235.
Authors:  Zhang,Zhizhuo;  Chng,Kern Rei;  Lingadahalli,Shreyas;  Chen,Zikai;  Liu,Mei Hui; et al.
Favorite | TC[WOS]:36 TC[Scopus]:37  IF:6.2/8.4 | Submit date：2021/03/02
Digitoxin synergizes with sorafenib to inhibit hepatocelluar carcinoma cell growth without inhibiting cell migration Journal article
Xia, Yijun, Yan, Wei, Guo, Libin, Meng, Chen, Li, Bin, Neves, Henrique, Chen, Peng-Chen, Li, Ling, Huang, Yide, Kwok, Hang Fai, Lin, Yao. Digitoxin synergizes with sorafenib to inhibit hepatocelluar carcinoma cell growth without inhibiting cell migration[J]. MOLECULAR MEDICINE REPORTS, 2017, 15(2), 941-947.
Authors:  Xia, Yijun;  Yan, Wei;  Guo, Libin;  Meng, Chen;  Li, Bin; et al.
Favorite | TC[WOS]:12 TC[Scopus]:12  IF:3.4/3.0 | Submit date：2018/10/30
Hepatocellular Carcinoma  Sorafenib  Digitoxin  Synergistic Inhibition